运动意象脑机接口在脑卒中后上肢运动功能障碍康复中的应用
September 1st, 2023
本研究旨在为脑卒中后上肢运动功能障碍运动意象脑机接口（MI-BCI）的标准临床操作提供重要参考。
本研究重点介绍MI-BCI在中重度上肢运动功能障碍脑卒中患者中的临床应用。并通过展示MI-BCI的操作过程和干预效果，为规范化的临床操作和机制研究提供思路和参考。MI-BCI对改善脑卒中患者的运动功能障碍具有积极作用。
然而，未来将进行更多该领域的临床研究，以针对中风患者这种不同功能水平的治疗方案进行更合适的治疗方案。本研究采用功能性近红外光谱（fNIRS）实时监测不同刺激任务下大脑皮层中血红蛋白和氧合血红蛋白的浓度变化。从而为MI-BCI的临床效果提供影像学证据。
我们提出了一项方案，将 MI-BCI 训练用于中风患者的上肢运动康复。MI-BCI治疗后，上肢Fugi-Meyer评估和Wolf运动功能测试均有所提高。同时，fNIRS评估还显示背外侧前额叶皮层、初级运动皮层和初级感觉皮层的激活更多。
研究结果表明，MI-BCI干预后，中风患者的运动和认知功能可能会得到改善。独创的上肢康复干预方法，可是外周介入或中枢介入。而MI-BCI则基于中心、外围和中心的闭环原理，或将中心模型与外围电机反馈相结合。
闭环原理更适合中枢神经系统疾病的特点。
View the full transcript and gain access to thousands of scientific videos
概览
本研究探索了运动意象脑机接口（MI-BCI）在增强中风患者上肢运动功能方面的临床应用。通过利用功能性近红外光谱（fNIRS），它旨在提供对MI-BCI干预机制和操作化的见解。研究结果表明对运动功能障碍有积极影响，可指导未来康复方案。
关键研究组成部分
科学领域
- 神经科学
- 康复
- 临床神经科学
背景
- 运动意象脑机接口（MI-BCI）是中风患者的新兴康复技术。
- 上肢运动功能障碍是中风的常见后果。
- 标准化MI-BCI的临床操作可以提高治疗效果。
研究目的
- 为MI-BCI的临床操作建立参考。
- 评估MI-BCI在改善中风患者运动功能障碍方面的有效性。
- 展示MI-BCI的操作过程和干预效果。
使用的方法
- 利用功能性近红外光谱（fNIRS）实时监测大脑皮层中血红蛋白浓度变化。
- 使用Fugl-Meyer和Wolf运动功能测试对MI-BCI干预前后进行评估。
- 遵循结构化的训练方案，根据患者表现进行EEG头盔放置和任务设置。
主要结果
- MI-BCI训练在治疗后显著改善了运动和认知功能。
- 在功能评估中观察到关键皮层区域的活化增加。
- 根据患者反馈和表现，展示了MI-BCI任务难度的适应性。
结论
- 该研究确立了MI-BCI作为中风康复中运动功能改善的可行干预措施。
- 研究结果主张需要进行更多研究以完善治疗方案并提高效果。
- 提供的操作框架可以支持进一步研究MI-BCI在中风护理中的神经可塑性效应。
常见问题
Executive Industry Relevance
Motor imagery brain-computer interface (MI-BCI) offers a non-invasive, mechanism-driven approach to address upper limb motor dysfunction in post-stroke rehabilitation, targeting a critical bottleneck in neurorestorative R&D. By integrating real-time neurophysiological monitoring and adaptive task protocols, MI-BCI enhances predictive confidence in functional recovery and supports translational continuity from mechanistic insight to clinical application. This capability is strategically positioned to inform portfolio decisions and de-risk early-stage neurorehabilitation assets.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of central-peripheral code loop mechanisms underlying motor recovery.
- Supports functional target validation through quantitative neuroimaging and behavioral endpoints.
- Facilitates mechanistic de-risking by linking cortical activation patterns to clinical function.
Screening & Assay Development
- Establishes standardized, reproducible MI-BCI protocols for evaluating neurorehabilitation interventions.
- Generates quantitative outputs via Fugl-Meyer and Wolf Motor Function Tests for objective assessment.
- Prepares validated patient cohorts and data streams for downstream screening of adjunctive therapies.
Translational & Preclinical Research
- Aligns functional near-infrared spectroscopy (fNIRS) biomarkers with disease-relevant motor and cognitive endpoints.
- Enables continuity from discovery-stage mechanistic studies to preclinical and early clinical validation.
- Supports risk-adjusted advancement by integrating neurophysiological and behavioral data.
Pipeline & Workflow Integration
MI-BCI protocols bridge early discovery, target validation, and translational research by providing standardized, quantitative, and mechanistically anchored assessments of neurorehabilitation interventions.
- Discovery Biology: Supports hypothesis testing of central-peripheral integration in motor recovery.
- Screening: Delivers reproducible, quantitative motor and cognitive function readouts for intervention assessment.
- Analytics: Provides real-time fNIRS and EEG data for comparative analysis across patient cohorts.
- Translational Research: Aligns functional and neuroimaging biomarkers for preclinical-to-clinical continuity.
- Enterprise Reuse: Offers a scalable, adaptable platform for ongoing neurorehabilitation R&D initiatives.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in neurorehabilitation outcomes and reduces mechanistic ambiguity.
- Operational Value: Standardizes patient assessment and intervention protocols for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions and optimizes resource allocation in neurorestorative portfolios.
- Portfolio Impact: Enables risk-adjusted prioritization of neurorehabilitation assets based on quantitative endpoints.
Implementation Considerations
- Requires expertise in neurophysiology, EEG/fNIRS instrumentation, and clinical assessment protocols.
- Demands robust analytical infrastructure for real-time data acquisition and processing.
- Necessitates cross-team standardization of training, assessment, and data management workflows.
- Adaptation across diverse patient populations and stroke severities may require protocol customization.
- Signal quality and patient compliance are practical limitations that must be managed during implementation.
